MedTrace Logo

Local Application of Vancomycin Powder in Grade I-IIIA Open Fractures

NCT02400112 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2018-11-29

No results posted yet for this study

Summary

The purpose of this study is to determine if local administration of vancomycin powder at the site of Grade I-IIIA open fractures at the time of surgery will be an efficacious method to lower infection rates in open fracture treatment and to elucidate any detrimental effects of applying vancomycin powder at the site of open fractures.

Conditions

  • Fractures, Open
  • Surgical Wound Infection

Interventions

DRUG

Vancomycin

Vancomycin powder administered locally, intraoperatively at site of open fracture

Sponsors & Collaborators

  • University of Tennessee

    lead OTHER

Principal Investigators

  • Dirk W Kiner, MD · University of Tennessee College of Medicine Chattanooga/Erlanger Health System

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02400112 on ClinicalTrials.gov